Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Potent inhibition of NFAT activation and T cell cytokine production by novel low molecular weight pyrazole compounds.
Trevillyan JM, Chiou XG, Chen YW, Ballaron SJ, Sheets MP, Smith ML, Wiedeman PE, Warrior U, Wilkins J, Gubbins EJ, Gagne GD, Fagerland J, Carter GW, Luly JR, Mollison KW, Djuric SW. Trevillyan JM, et al. Among authors: fagerland j. J Biol Chem. 2001 Dec 21;276(51):48118-26. doi: 10.1074/jbc.M107919200. Epub 2001 Oct 9. J Biol Chem. 2001. PMID: 11592964 Free article.
Ultrastructural analysis in preclinical safety evaluation.
Fagerland JA, Wall HG, Pandher K, LeRoy BE, Gagne GD. Fagerland JA, et al. Toxicol Pathol. 2012;40(2):391-402. doi: 10.1177/0192623311430239. Epub 2012 Jan 3. Toxicol Pathol. 2012. PMID: 22215513 Review.
A quantitation method for mass spectrometry imaging.
Koeniger SL, Talaty N, Luo Y, Ready D, Voorbach M, Seifert T, Cepa S, Fagerland JA, Bouska J, Buck W, Johnson RW, Spanton S. Koeniger SL, et al. Among authors: fagerland ja. Rapid Commun Mass Spectrom. 2011 Feb 28;25(4):503-10. doi: 10.1002/rcm.4891. Rapid Commun Mass Spectrom. 2011. PMID: 21259359
The role of the toxicologic pathologist in the biopharmaceutical industry.
van Tongeren S, Fagerland JA, Conner MW, Diegel K, Donnelly K, Grubor B, Lopez-Martinez A, Bolliger AP, Sharma A, Tannehill-Gregg S, Turner PV, Wancket LM. van Tongeren S, et al. Among authors: fagerland ja. Int J Toxicol. 2011 Oct;30(5):568-82. doi: 10.1177/1091581811413304. Epub 2011 Aug 30. Int J Toxicol. 2011. PMID: 21878555 Review.
A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity.
Müller L, Mauthe RJ, Riley CM, Andino MM, Antonis DD, Beels C, DeGeorge J, De Knaep AG, Ellison D, Fagerland JA, Frank R, Fritschel B, Galloway S, Harpur E, Humfrey CD, Jacks AS, Jagota N, Mackinnon J, Mohan G, Ness DK, O'Donovan MR, Smith MD, Vudathala G, Yotti L. Müller L, et al. Among authors: fagerland ja. Regul Toxicol Pharmacol. 2006 Apr;44(3):198-211. doi: 10.1016/j.yrtph.2005.12.001. Epub 2006 Jan 18. Regul Toxicol Pharmacol. 2006. PMID: 16412543
30 results